Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues

On: February 13, 2017

In: Botox, Journal Articles

Condition: Cluster Headache
Interventions: Drug: Botulinum Toxin Type A 25 IU; Drug: Botulinum Toxin Type A 12.5 IU
Sponsors: Norwegian University of Science and Technology; St. Olavs Hospital
Recruiting – verified April 2017
Source: Cluster Headache Clinical Trials

Related

Previous Post: Cluster headache and other TACs: Pathophysiology and neurostimulation options

Next Post: Effects of non-invasive vagus nerve stimulation on attack frequency over time and expanded response rates in patients with chronic cluster headache: a post hoc analysis of the randomised, controlled PREVA study